OTCM
HGYN
, Last price
USD
Name
Hong Yuan Holding Group
Chart & performance
P/E
—
P/B
—
EPS
0.00
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
838k
+241.14%
Net income
158k
P
CFO
-28k
L-68.25%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hong Yuan Holding Group presently conducts no substantial business operations. Historically, the company's primary focus lay in the advancement and commercialization of bio-derived resins. It operated under the name Cereplast, Inc. until June 2021, when it officially adopted its current designation. Established in 2001, the entity's headquarters are situated in Zhengzhou, China.
Key people
Chief Financial Officer, Senior Vice President · since 2013
Mark Barton
Senior Vice President - Operations · since 2008
Kelvin T Okamoto
Senior Vice President, Chief Technology Officer · since 2011
Frederic Scheer
Chairman of the Board, Chief Executive Officer, Founder · since 2008
Franklin L. Hunt
Independent Director · since 2010
Paul Francis Pelosi
Independent Director · since 2012
Craig Robert Peus
Independent Director · since 2010
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||